Human monoclonal antibodies to neutralize all dengue virus serotypes using lymphocytes from patients at acute phase of the secondary infection.

Abstract

The global spread of the four dengue virus serotypes (DENV-1 to -4) has made this virus a major and growing public health concern. Generally, pre-existing neutralizing antibodies derived from primary infection play a significant role in protecting against subsequent infection with the same serotype. By contrast, these pre-existing antibodies are believed to mediate a non-protective response to subsequent heterotypic DENV infections, leading to the onset of dengue illness. In this study, we prepared hybridomas producing human monoclonal antibodies (HuMAbs) against DENV using peripheral blood mononuclear cells (PBMCs) from patients in the acute phase (around 1 week after the onset of illness) or the convalescent phase (around 2weeks after the onset of illness) of secondary infection. Interestingly, a larger number of hybridoma clones was obtained from patients in the acute phase than from those in the convalescent phase. Most HuMAbs from acute-phase infections were cross-reactive with all four DENV serotypes and showed significant neutralization activity to all four DENV serotypes. Thus, secondary DENV infection plays a significant role in stimulating memory cells to transiently increase the number of antibody-secreting plasma cells in patients in the early phase after the secondary infection. These HuMAbs will enable us to better understand the protective and pathogenic effects of DENV infection, which could vary greatly among secondarily-infected individuals.

DOI: 10.1016/j.bbrc.2012.06.057
0102030201520162017
Citations per Year

Citation Velocity: 8

Averaging 8 citations per year over the last 3 years.

Learn more about how we calculate this metric in our FAQ.

Cite this paper

@article{Setthapramote2012HumanMA, title={Human monoclonal antibodies to neutralize all dengue virus serotypes using lymphocytes from patients at acute phase of the secondary infection.}, author={Chayanee Setthapramote and Tadahiro Sasaki and Orapim Puiprom and Kriengsak Limkittikul and Pannamthip Pitaksajjakul and Chonlatip Pipattanaboon and Mikiko Sasayama and Pornsawan Leuangwutiwong and Weerapong Phumratanaprapin and Supat Chamnachanan and Teera Kusolsuk and Akanitt Jittmittraphap and Azusa Asai and Juan F. Arias and Itaru Hirai and Motoki Kuhara and Yoshinobu Okuno and Takeshi Kurosu and Pongrama Ramasoota and Kazuyoshi Ikuta}, journal={Biochemical and biophysical research communications}, year={2012}, volume={423 4}, pages={867-72} }